View in EDS HTML Full Text PDF Full Text

The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.

Saved in:
Bibliographic Details
Title: The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.
Authors: Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Staudt L; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA., Takebe N; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA., Wheeler DA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cardenas MF; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Korchina V; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Zenklusen JC; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA., McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Lubensky I; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., O'Sullivan-Coyne G; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA., Kohn E; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., White J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Malik S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Mann B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Weil C; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Tarnuzzer R; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA., Karlovich C; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Rodgers B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Shankar L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Jacobs PM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Nolan T; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Berryman SM; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Gastier-Foster J; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA., Bowen J; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA., Leraas K; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA., Shen H; Van Andel Research Institute, Grand Rapids, MI, USA., Laird PW; Van Andel Research Institute, Grand Rapids, MI, USA., Esteller M; Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, Spain., Miller V; Foundation Medicine Inc, Cambridge, MA, USA., Johnson A; Foundation Medicine Inc, Cambridge, MA, USA., Edmondson EF; Pathology and Histology Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Giordano TJ; Department of Pathology, University of Michigan, Ann Arbor, MI, USA., Kim B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 27-37.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32339229
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Conley+BA%22">Conley BA</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Staudt+L%22">Staudt L</searchLink>; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Takebe+N%22">Takebe N</searchLink>; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Wheeler+DA%22">Wheeler DA</searchLink>; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Cardenas+MF%22">Cardenas MF</searchLink>; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Korchina+V%22">Korchina V</searchLink>; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Zenklusen+JC%22">Zenklusen JC</searchLink>; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22McShane+LM%22">McShane LM</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Tricoli+JV%22">Tricoli JV</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Williams+PM%22">Williams PM</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lubensky+I%22">Lubensky I</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22O'Sullivan-Coyne+G%22">O'Sullivan-Coyne G</searchLink>; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kohn+E%22">Kohn E</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Little+RF%22">Little RF</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22White+J%22">White J</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Malik+S%22">Malik S</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Harris+LN%22">Harris LN</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mann+B%22">Mann B</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Weil+C%22">Weil C</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Tarnuzzer+R%22">Tarnuzzer R</searchLink>; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Karlovich+C%22">Karlovich C</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Rodgers+B%22">Rodgers B</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Shankar+L%22">Shankar L</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Jacobs+PM%22">Jacobs PM</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Nolan+T%22">Nolan T</searchLink>; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.<br /><searchLink fieldCode="AU" term="%22Berryman+SM%22">Berryman SM</searchLink>; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.<br /><searchLink fieldCode="AU" term="%22Gastier-Foster+J%22">Gastier-Foster J</searchLink>; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA.<br /><searchLink fieldCode="AU" term="%22Bowen+J%22">Bowen J</searchLink>; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA.<br /><searchLink fieldCode="AU" term="%22Leraas+K%22">Leraas K</searchLink>; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA.<br /><searchLink fieldCode="AU" term="%22Shen+H%22">Shen H</searchLink>; Van Andel Research Institute, Grand Rapids, MI, USA.<br /><searchLink fieldCode="AU" term="%22Laird+PW%22">Laird PW</searchLink>; Van Andel Research Institute, Grand Rapids, MI, USA.<br /><searchLink fieldCode="AU" term="%22Esteller+M%22">Esteller M</searchLink>; Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Miller+V%22">Miller V</searchLink>; Foundation Medicine Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+A%22">Johnson A</searchLink>; Foundation Medicine Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Edmondson+EF%22">Edmondson EF</searchLink>; Pathology and Histology Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Giordano+TJ%22">Giordano TJ</searchLink>; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Kim+B%22">Kim B</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ivy+SP%22">Ivy SP</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227503089%22">Journal of the National Cancer Institute</searchLink> [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 27-37.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7503089 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278874%22">00278874 </searchLink><i>NLM ISO Abbreviation: </i>J Natl Cancer Inst <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32339229
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jnci/djaa061
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 27
    Titles:
      – TitleFull: The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Conley BA
      – PersonEntity:
          Name:
            NameFull: Staudt L
      – PersonEntity:
          Name:
            NameFull: Takebe N
      – PersonEntity:
          Name:
            NameFull: Wheeler DA
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Cardenas MF
      – PersonEntity:
          Name:
            NameFull: Korchina V
      – PersonEntity:
          Name:
            NameFull: Zenklusen JC
      – PersonEntity:
          Name:
            NameFull: McShane LM
      – PersonEntity:
          Name:
            NameFull: Tricoli JV
      – PersonEntity:
          Name:
            NameFull: Williams PM
      – PersonEntity:
          Name:
            NameFull: Lubensky I
      – PersonEntity:
          Name:
            NameFull: O'Sullivan-Coyne G
      – PersonEntity:
          Name:
            NameFull: Kohn E
      – PersonEntity:
          Name:
            NameFull: Little RF
      – PersonEntity:
          Name:
            NameFull: White J
      – PersonEntity:
          Name:
            NameFull: Malik S
      – PersonEntity:
          Name:
            NameFull: Harris LN
      – PersonEntity:
          Name:
            NameFull: Mann B
      – PersonEntity:
          Name:
            NameFull: Weil C
      – PersonEntity:
          Name:
            NameFull: Tarnuzzer R
      – PersonEntity:
          Name:
            NameFull: Karlovich C
      – PersonEntity:
          Name:
            NameFull: Rodgers B
      – PersonEntity:
          Name:
            NameFull: Shankar L
      – PersonEntity:
          Name:
            NameFull: Jacobs PM
      – PersonEntity:
          Name:
            NameFull: Nolan T
      – PersonEntity:
          Name:
            NameFull: Berryman SM
      – PersonEntity:
          Name:
            NameFull: Gastier-Foster J
      – PersonEntity:
          Name:
            NameFull: Bowen J
      – PersonEntity:
          Name:
            NameFull: Leraas K
      – PersonEntity:
          Name:
            NameFull: Shen H
      – PersonEntity:
          Name:
            NameFull: Laird PW
      – PersonEntity:
          Name:
            NameFull: Esteller M
      – PersonEntity:
          Name:
            NameFull: Miller V
      – PersonEntity:
          Name:
            NameFull: Johnson A
      – PersonEntity:
          Name:
            NameFull: Edmondson EF
      – PersonEntity:
          Name:
            NameFull: Giordano TJ
      – PersonEntity:
          Name:
            NameFull: Kim B
      – PersonEntity:
          Name:
            NameFull: Ivy SP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 01
              Text: 2021 Jan 04
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1460-2105
          Numbering:
            – Type: volume
              Value: 113
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of the National Cancer Institute
              Type: main
ResultId 1